Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Multi-Center, Randomized, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Mild to Moderate Hypertension

NCT00200434 is registered in ClinicalTrials.gov with Mylan Bertek Pharmaceuticals as lead sponsor.

NCT NCT00200434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00200434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Multi-Center, Randomized, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Mild to Moderate Hypertension
Lead sponsor
Mylan Bertek Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2002
Completion date
October 31, 2003
Enrollment
600
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension